
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Because many gay men who are HIV-positive begin antiretroviral therapy earlier than people in other risk groups, their vigilance probably results in a better immune response to treatment, researchers report in the November edition of HIV Medicine. Hoping to determine if risk group or a person's sex had an effect on the decision of when to start therapy and a patient's response to treatment, the researchers studied a cohort of over 5,000 patients from 62 hospitals across France. After the two-year mark they found that gay men had begun therapy in higher proportion than any other group: 38% versus 33% for heterosexuals and 31% for injection drug users. As a result, the researchers conclude, gay men more quickly reached the success benchmark of a minimum 100 CD4-cell increase than all other groups studied. In support of treatment guidelines recommended by some of the world's leading HIV physicians and researchers that treatment should be started while a patient's CD4-cell count is above 350, the French researchers point out that in their study more than half of the gay men initiated therapy while their CD4 count was above 350, while only 36% of heterosexuals in the cohort and 34% of the injection-drug users did so.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video